Related Experiment Videos

[Beta adrenergic receptors in circulating lymphocytes of patients with chronic heart failure]

E Guarda1, R Corbalan, S Lavandero

  • 1Departamento de Enfermedades Cardiovasculares, Pontificia Universidad Católica de Chile, Santiago de Chile.

Revista Medica De Chile
|June 1, 1990
PubMed

Insights

Patients with chronic heart failure have fewer beta-adrenergic receptors on lymphocytes. This decrease in beta receptors may be linked to higher circulating catecholamines, especially during exercise.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pharmacology

Context:

  • Chronic heart failure (CHF) is characterized by neurohormonal dysregulation.
  • Elevated circulating catecholamines and reduced myocardial beta-adrenergic receptors are hallmarks of severe CHF.
  • Lymphocytes serve as a surrogate for studying adrenergic receptor density in vivo.

Purpose:

  • To investigate the density of beta-adrenergic receptors and cyclic AMP (cAMP) levels in circulating lymphocytes of patients with stable, class II-III heart failure.
  • To compare these values with those of healthy controls.

Summary:

  • This study examined 14 patients with stable heart failure and 10 healthy controls.
  • Results showed a significant reduction in the number of beta-adrenergic receptors on lymphocytes in heart failure patients (105 +/- 16 fmol/mg protein) compared to controls (185 +/- 24 fmol/mg protein, p < 0.01).
  • No significant differences were observed in the dissociation constant (Kd) or intracellular cAMP levels between the groups.

Impact:

  • The findings suggest that decreased beta-adrenergic receptor density on circulating lymphocytes is a feature of stable heart failure.
  • This reduction may be associated with elevated circulating catecholamines, potentially exacerbated during physical activity.
  • Understanding these alterations can inform therapeutic strategies targeting the adrenergic system in heart failure management.

Related Concept Videos